KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Capital Employed (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Capital Employed over the past 15 years, most recently at 0.02% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.02% for Q4 2025, down 8.0% from a year ago — trailing twelve months through Dec 2025 was 0.02% (down 8.0% YoY), and the annual figure for FY2025 was 0.04%, down 11.0%.
  • Return on Capital Employed for Q4 2025 was 0.02% at Jazz Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Capital Employed for JAZZ hit a ceiling of 0.12% in Q1 2021 and a floor of 0.02% in Q3 2025.
  • Median Return on Capital Employed over the past 5 years was 0.02% (2022), compared with a mean of 0.03%.
  • Biggest five-year swings in Return on Capital Employed: grew 8bps in 2021 and later decreased -12bps in 2022.
  • Jazz Pharmaceuticals' Return on Capital Employed stood at 0.01% in 2021, then plummeted by -146bps to 0.01% in 2022, then surged by 975bps to 0.06% in 2023, then grew by 9bps to 0.06% in 2024, then crashed by -131bps to 0.02% in 2025.
  • The last three reported values for Return on Capital Employed were 0.02% (Q4 2025), 0.02% (Q3 2025), and 0.0% (Q2 2025) per Business Quant data.